Recently, several studies have shown that DPP-4 inhibitors and GLP-1R agonists exert also a potent anti-inflammatory effect and thus, may potentially contribute to the prevention of atherosclerosis (Chaudhuri et al., 2012; Makdissi et al., 2012). The gene discussed is DPP4; the disease is atherosclerosis.